Steve Tregay
InvestorManaging Partner at Mission Biocapital
Cambridge, Massachusetts
Writes $500K checks · typically $1.5M
FoundedAlessa Therapeutics
About
Steve Tregay, a big‑pharma executive, venture capitalist and biotech founder‑CEO, serves as founding CEO and guides companies from research to clinical development while chairing LabCentral, building shared labs in Cambridge.
Invests in
AgTechBiotechFoodTechHealthtechMedical DevicesNew Materials
Experience
- Mission BioCapitalManaging General Partnercurrent2019 — presentCambridge, MA
- FORMA TherapeuticsFounder, President and CEO2008 — 2019
- Compass Therapeutics LLCFounder and Chairman of the Board of Directors2015 — 2019Cambridge MA
- Novartis Venture FundManaging Director2006 — 2009
- Novartis Institutes for BioMedical Research (NIBR)Executive Director2004 — 2006
- Array BioPharmaBusiness Development2001 — 2004
Education
- Harvard UniversityPh.D., MS1993 — 1999
- Davidson CollegeBS, Chemistry1989 — 1993
Skills & more
Drug Discovery99Biotechnology99Pharmaceutical Industry99Drug Design21Drug Development94Medicinal Chemistry23Oncology99Lifesciences37Technology Transfer47Clinical Development41CRO14Cancer9
+12 more
ChemistryOrganic ChemistryBiopharmaceuticalsCommercializationNeuroscienceGLPBiomarkersVenture CapitalClinical TrialsBiochemistryPharmacologyGMPFrom Steve's professional profile.
Same school
Also attended Harvard University1,231
Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGRyan IsonoDeal Partner at Felicis Ventures
+ 1,225 more
Also attended Davidson College43
Robert MorrisInvestor at Y CombinatorDaniel HanksManaging Partner at Lavrock VenturesGray RobinsonPartner at Congruent VenturesJon BassettManaging Partner at NextGen Venture PartnersJohn PhilpottPartner at FINTOP CapitalAndy SchwabManaging Partner at 5AM Ventures
+ 37 more
Shared employers
Also worked at Compass Therapeutics LLC8
Errik AndersonBoard Director at Basecamp FundMike SchmidtGeneral Partner, President and Head of 82VS Boston at 82VSErrik AndersonGeneral Partner at 82VSErrik AndersonBoard Director at Alumni VenturesPhil FerneauManaging Partner at Borealis VenturesUgur EskiocakFounder / EIR at 82VS
+ 2 more
Also worked at Novartis Institutes for BioMedical Research (NIBR)105
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 99 more
Deals · 1
Compass Therapeutics LLCBoard seat
via Mission Biocapital · filed Jul 2018 · $170.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Mission Biocapital
Cassidy Blundell
Partner at Mission Biocapital
Chaya Patel
Principal at Mission Biocapital
Chris Carlin
Chief Operations Officer and Chief Compliance Officer at Mission Biocapital
Clay Rowland
Investment Associate at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Helen Siaw
Analyst at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital


























